Supernus Pharmaceuticals | SUPN - EPS Earnings Per Share


Supernus Pharmaceuticals reported $-1.01 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 0.59 -0.80 Oct/29
FY2026Q2 Jun/2026 -1.01 0.43 0.40 Aug/03
FY2026Q1 Mar/2026 0.60 0.52 -0.21 May/05
FY2025Q4 Dec/2025 -0.07 0.41 0.27 Feb/24
FY2025Q3 Sep/2025 -0.80 0.37 0.69 Nov/04




Eps Change Date
Abbott USD 0.53 0.78 Sep/2026
ANI Pharmaceuticals USD 2.21 0.16 Jun/2026
Aurora Cannabis CAD -0.13 0.51 Mar/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Canopy Growth CAD -0.4 0.35 Mar/2026
Cara Therapeutics USD -0.72 0.14 Mar/2026
Corcept Therapeutics USD 0.36 0.66 Jun/2026
Eisai JPY 64.71 76.24 Jun/2026
Eli Lilly USD 8.38 0.17 Jun/2026
Novo Nordisk DKK 4.74 6.17 Jun/2026
Pacira USD 0.73 0.13 Jun/2026
Perrigo USD 0.5 0.07 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Supernus Pharmaceuticals USD -1.01 1.61 Jun/2026
United Therapeutics USD 7.27 1.45 Jun/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026